Evergreen Nephrology is a company focused on transforming kidney care by empowering nephrologists to provide high-quality and personalized care to patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). By putting nephrologists at the forefront, the company provides them with financial backing, interdisciplinary clinical resources, analytical insights, and technology-enabled tools to improve patient outcomes and experience. Evergreen Nephrology collaborates with strategic partners to address healthcare challenges, including disparate electronic health records (EHRs), transplantation process visibility, and patient readmission risks. The company's co-founders, Adam Boehler and Abe Sutton, have been recognized for their contributions to kidney care models and organ procurement standards, reflecting a deep commitment to improving kidney care quality nationwide.